-
Mashup Score: 4Scientific writing: how to get published | Published in Clinical Hematology International - 4 month(s) ago
By Junia Melo, Mohamad Mohty. Publishing scientific and medical papers is a key component of an academic career.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Scientific writing: how to get published | Published in Clinical Hematology International - 4 month(s) ago
By Junia Melo, Mohamad Mohty. Publishing scientific and medical papers is a key component of an academic career.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
Scientific writing: how to get published https://t.co/ZfGPBo7L9t via @Mohty_EBMT et al
-
-
Mashup Score: 21Single-cell genomics-based immune and disease monitoring in blood malignancies | Published in Clinical Hematology International - 5 month(s) ago
By Anja C. Rathgeber, Leif S. Ludwig & 1 more. As single-cell immune monitoring tools evolve and become more accessible, we expect their wide adoption for routine clinical applications to catalyze more precise therapeutic steering of personal immune responses.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
«Single-cell genomics-based immune and disease monitoring in blood malignancies» A comprehensive review published in Clin Hematol Int, the official academic peer reviewed open access journal of @TheIACH - No page charges or other hidden publication fees. https://t.co/Ed0KpOD2h8
-
-
Mashup Score: 59How I treat newly diagnosed acute lymphoblastic leukemia | Published in Clinical Hematology International - 5 month(s) ago
By Giebel Sebastian. Treatment algorithms differ for adult patients with Philadelphia-negative (Ph-) and Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL).
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
«How I treat newly diagnosed acute lymphoblastic leukemia» - A comprehensive review published in Clin Hematol Int, the official academic peer reviewed open access journal of @TheIACH - No page charges or other hidden publication fees. https://t.co/hcnG97fScF
-
-
Mashup Score: 20Single-cell genomics-based immune and disease monitoring in blood malignancies | Published in Clinical Hematology International - 5 month(s) ago
By Anja C. Rathgeber, Leif S. Ludwig & 1 more. As single-cell immune monitoring tools evolve and become more accessible, we expect their wide adoption for routine clinical applications to catalyze more precise therapeutic steering of personal immune responses.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
Single-cell genomics-based immune and disease monitoring in blood malignancies just published in “Clin Hematol Int”, the official open access peer-reviewed journal of @TheIACH - this is very a timely review in light of the advances at #EHA24 https://t.co/n3OGOXvRam
-
-
Mashup Score: 23Elranatamab treatment in a multiple myeloma patient undergoing renal dialysis | Published in Clinical Hematology International - 6 month(s) ago
By Zoé Van de Wyngaert, Irene Romera-Martinez & 6 more. Despite end-stage renal impairment, treatment with the anti-B cell maturation antigen (BCMA)xCD3 bispecific antibody proved feasible without unexpected side effects. Increased attention to infectious risk is crucial for fragile patients.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
Elranatamab treatment in a myeloma patient undergoing renal dialysis- Published in Clin Hematol Int the official journal of @TheIACH @IMFmyeloma @MyelomaTeacher @MyelomaUK @Florent_Malard @af3m_myelome https://t.co/EKa1l0Mxsz
-
-
Mashup Score: 15Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy | Published in Clinical Hematology International - 6 month(s) ago
By Nausheen Ahmed, Olalekan Oluwole & 3 more. We recommend re-immunizing patients post CAR-T based on CDC and transplant guidelines.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
RT @NausheenAhmedMD: Our comprehensive review on #infections in #CART is finally out. https://t.co/vKbOeJI0Fn @kczmj https://t.co/M7PtpOwVvO
-
-
Mashup Score: 15Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy | Published in Clinical Hematology International - 6 month(s) ago
By Nausheen Ahmed, Olalekan Oluwole & 3 more. We recommend re-immunizing patients post CAR-T based on CDC and transplant guidelines.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
RT @NausheenAhmedMD: Our comprehensive review on #infections in #CART is finally out. https://t.co/vKbOeJI0Fn @kczmj https://t.co/M7PtpOwVvO
-
-
Mashup Score: 49
By Jana Sawyer, Taylor Elliott & 4 more. The acute toxicities that occur from conditioning chemotherapy can impact the peri-transplant period and have substantial implications on patients’ tolerability and outcomes, irrespective of the treatment of their disease.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
«Prevention and management of acute toxicities from conditioning regimens during HSCT» published in Clin Hematol Int, the official peer-reviewed academic open access journal of @TheIACH - No submission fees, page charges or other hidden costs https://t.co/YllNLkhu97
-
-
Mashup Score: 29
By Allison C. Y. Tso, Sanchalika Acharyya & 6 more. Real-world data on the outcome of Asian patients with secondary hemophagocytic lymphohistiocytosis (HLH), especially on dengue-associated HLH, are limited to small case series.
Source: chi.scholasticahq.comCategories: General Medicine News, Hem/OncsTweet-
«A Retrospective Review of Secondary Hemophagocytic Lymphohistiocytosis (HLH) and Dengue-associated HLH» Published in Clin Hematol Int, the official journal of @TheIACH - A rare but serious complication. https://t.co/6YbkDFvJSg
-
Scientific writing: how to get published https://t.co/ZfGPBo7L9t via @Mohty_EBMT et al